Xconomy San Diego

Actimis Pharmaceuticals Lands $9,600,000 New Round

  • Feed Type
  • Date
    6/30/2008
  • Company Name
    Actimis Pharmaceuticals
  • Mailing Address
    10835 Road To The Cure San Diego, CA 92121
  • Company Description
    Actimis Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused exclusively on the development and commercialization of small molecule therapeutics for severe respiratory, inflammatory and autoimmune diseases such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory dermatoses, inflammatory bowel disease and rheumatoid arthritis.
  • Website
    http://www.actimis.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $9,600,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Sanderling Ventures
  • Venture Investor
    Undisclosed

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.